| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |